GCTK Glucotrack, Inc.
Nasdaq · SEC CIK 1506983 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 15 since 2024-04-24, latest 2025-10-07
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| No open-market trades in the last year. | |||
Transactions 22
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-07 | 2025-03-25 | GCTK | Goode Paul | CEO, Dir | J - Other | — | +42 | 339 | +14% | — | |
| DM | 2025-10-07 | 2025-03-25+ | GCTK | Carter Erin Catherine | Dir | A - Grant | $0.00 | +1,418 | 762 | New | $0 |
| DM | 2025-10-07 | 2025-03-25+ | GCTK | Balo Andrew K | Dir | A - Grant | $0.00 | +4,692 | 75 | New | $0 |
| DM | 2025-10-07 | 2025-03-25+ | GCTK | Malave Luis | Dir | A - Grant | $0.00 | +1,698 | 4,058 | +72% | $0 |
| D | 2025-03-31 | 2024-11-14 | GCTK | Malave Luis | Dir | C - Cnv Deriv | $31.20 | +6,886 | 8,009 | +613% | +$214.8K |
| DM | 2025-03-31 | 2021-09-30+ | GCTK | Malave Luis | Dir | A - Grant | $0.00 | +3,199 | 272 | New | $0 |
| D | 2025-03-31 | 2025-03-12 | GCTK | Malave Luis | Dir | X - OptEx | $0.00 | +133.5K | 141.5K | +1,667% | $0 |
| D | 2025-03-31 | 2025-03-12 | GCTK | John A. Ballantyne Revocable Living Trust dated 08/01/2017 | 10% | X - OptEx | $0.00 | +2.56M | 2.74M | +1,399% | $0 |
| D | 2025-03-31 | 2024-11-14 | GCTK | John A. Ballantyne Revocable Living Trust dated 08/01/2017 | 10% | J - Other | $31.00 | +132.0K | 183.0K | +259% | +$4.09M |
| D | 2025-03-31 | 2024-11-14 | GCTK | Carter Erin Catherine | Dir | C - Cnv Deriv | $31.20 | +2,078 | 3,439 | +153% | +$64.8K |
| DM | 2025-03-31 | 2023-12-31+ | GCTK | Carter Erin Catherine | Dir | A - Grant | $0.00 | +3,257 | 903 | New | $0 |
| D | 2025-03-31 | 2025-03-12 | GCTK | Carter Erin Catherine | Dir | X - OptEx | $0.00 | +40.3K | 43.7K | +1,172% | $0 |
| DI | 2025-03-31 | 2024-11-14 | GCTK | BALLANTYNE JOHN | Dir, 10% | J - Other | $31.00 | +132.0K | 183.0K | +259% | +$4.09M |
| D | 2025-03-31 | 2025-03-26 | GCTK | BALLANTYNE JOHN | Dir, 10% | A - Grant | $0.00 | +4,126 | 4,126 | New | $0 |
| DI | 2025-03-31 | 2025-03-12 | GCTK | BALLANTYNE JOHN | Dir, 10% | X - OptEx | $0.00 | +2.56M | 2.74M | +1,399% | $0 |
| D | 2025-03-28 | 2025-03-12 | GCTK | Goode Paul | CEO, Dir | X - OptEx | $0.00 | +15.4K | 19.0K | +434% | $0 |
| D | 2025-03-28 | 2025-02-05 | GCTK | Goode Paul | CEO, Dir | J - Other | — | +1,500 | 3,554 | +73% | — |
| D | 2025-03-28 | 2024-11-14 | GCTK | Goode Paul | CEO, Dir | C - Cnv Deriv | $31.20 | +796 | 2,054 | +63% | +$24.8K |
| M | 2025-03-28 | 2021-08-24+ | GCTK | Fischell Robert | Dir | A - Grant | $0.00 | +2,045 | 547 | New | $0 |
| 2025-03-28 | 2025-03-26 | GCTK | Balo Andrew K | Dir | A - Grant | $0.00 | +4,490 | 4,490 | New | $0 | |
| M | 2025-03-28 | 2022-10-04+ | GCTK | Danzig Allen | Dir | A - Grant | $0.00 | +1,771 | 1,922 | +1,173% | $0 |
| 2024-04-24 | 2024-04-22 | GCTK | SYCOFF DREW | Dir, 10% | P - Purchase | $1.26 | +182.5K | 2.95M | +7% | +$230.0K |
Purchase Sale Sale after option exercise All abbreviations